<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stool DNA testing adoption &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/stool-dna-testing-adoption/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 21 Oct 2025 15:23:56 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Stool DNA testing adoption &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Shifts in Colorectal Cancer Screening Methods Among Insured Populations</title>
		<link>https://bioengineer.org/shifts-in-colorectal-cancer-screening-methods-among-insured-populations/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 21 Oct 2025 15:23:45 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Colorectal cancer screening trends]]></category>
		<category><![CDATA[COVID-19 healthcare impact]]></category>
		<category><![CDATA[health disparities in oncology]]></category>
		<category><![CDATA[Patient-centric diagnostics]]></category>
		<category><![CDATA[Stool DNA testing adoption]]></category>
		<guid isPermaLink="false">https://bioengineer.org/shifts-in-colorectal-cancer-screening-methods-among-insured-populations/</guid>

					<description><![CDATA[In the wake of the COVID-19 pandemic, a comprehensive study focusing on colorectal cancer screening practices among privately insured individuals reveals nuanced shifts in diagnostic test utilization, shedding light on broader public health dynamics shaped by unprecedented global disruptions. This detailed investigation highlights not only the overall decline in conventional colorectal screening methods such as [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">284476</post-id>	</item>
	</channel>
</rss>
